InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,660.00
(
0.33%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.15
(
0.23%
)
Bitcoin
62,835.50
(
-0.34%
)
Post# of 363
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

scotty12

Send PM Follow Ignore
Followers 0
Posts 31
Boards Moderated 0
Alias Born 06/12/2010

scotty12

Re: scotty12 post# 351

Friday, 11/09/2012 5:32:19 PM

Friday, November 09, 2012 5:32:19 PM

Post# of 363
Eli Lilly and Applied Neurosolutions have an agreement which, while certain timelines are fulfilled, increases the income and research potential in finding a viable drug for Alzheimer's disease. Dr. Peter Davies is a well renowned, world renowned research analyst for Alzheimer's, he's under contract with Applied Neurosolution's for this very reason. Pfizer and Johnson & Johnson have given up research and development of a viable drug, for now.

Keep abreast of updates, successes and failures of trials for the drug Solanezumub and you'll begin to understand the potential capital gains your investment will provide.

Google Applied Neurosolutions every once in awhile as development of this drug and FDA approval will eventually come...


Be Well...
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up